Leukemia Clinical Trials

Showing 2141-2160 of 5,235 trials

A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma

NCT06143579

This is a single term, open label, single Center, Phase II Trial. The study is to explore the efficacy and safety of FOLFOX-HAIC combined with Lenvatinib and Envolizumab in the treatment of patients with potentially resectable HCC.

Potentially Resectable Hepatocellular Carcinoma

Sun Yat-sen University48 participantsStarted Dec 2023

COMPLETEDPhase 1

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

NCT01523223

This phase 1 trial studies the side effects and the best dose of donor CD8+ memory T-cells in treating patients with hematolymphoid malignancies. Giving low dose of chemotherapy before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells. The donated stem cells may replace the patient's immune cells and help destroy any remaining cancer cells (graft-versus-cancer effects). Giving an infusion of the donor's T cells (donor lymphocyte infusion) after the transplant may help increase this effect

Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)+31 more

Robert Lowsky16 participantsStarted Jan 2012

Stanford, California, United States

A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

Related Searches

Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease

Long-Term Follow-Up Study of Patients Receiving ATL001

Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression

CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study

Effect of Intra-Canal Cryotherapy on Postoperative Pain After Endodontic Procedures

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML

A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer

1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon

K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation

Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC

Addressing Palliative Care Needs Among Intensive Care Unit Family Members

First Line Osimertinib in the Real World: an Inter-regional Prospective Study